{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:41:25Z","timestamp":1793479285310,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J NeuroEngineering Rehabil"],"DOI":"10.1186\/s12984-025-01640-w","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:40:14Z","timestamp":1749620414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combining immersive exergaming with physiotherapy in a specialized intensive Parkinson\u2019s disease rehabilitation program: a randomized controlled trial"],"prefix":"10.1186","volume":"22","author":[{"given":"Daniela","family":"Pimenta Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Bou\u00e7a-Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Pona-Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Cacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Krakauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"11","key":"1640_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.parkreldis.2014.09.013","volume":"20","author":"A Rizos","year":"2014","unstructured":"Rizos A, Martinez-Martin P, Odin P, Antonini A, Kessel B, Kozul TK, et al. Characterizing motor and non-motor aspects of early-morning off periods in Parkinson\u2019s disease: an international multicenter study. Parkinsonism Relat Disord. 2014;20(11):1231\u20135.","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"1640_CR2","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.neuron.2019.03.004","volume":"101","author":"MM McGregor","year":"2019","unstructured":"McGregor MM, Nelson AB. Circuit mechanisms of Parkinson\u2019s disease. Neuron. 2019;101(6):1042\u201356.","journal-title":"Neuron"},{"key":"1640_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnana.2015.00005","volume":"9","author":"A Galvan","year":"2015","unstructured":"Galvan A, Devergnas A, Wichmann T. Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state. Front Neuroanat. 2015;9:5.","journal-title":"Front Neuroanat"},{"issue":"11","key":"1640_CR4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nrn2915","volume":"11","author":"P Redgrave","year":"2010","unstructured":"Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, et al. Goal-directed and habitual control in the basal ganglia: implications for Parkinson\u2019s disease. Nat Rev Neurosci. 2010;11(11):760\u201372.","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"1640_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/cercor\/bhp178","volume":"20","author":"RC Helmich","year":"2010","unstructured":"Helmich RC, Derikx LC, Bakker M, Scheeringa R, Bloem BR, Toni I. Spatial remapping of cortico-striatal connectivity in Parkinson\u2019s disease. Cereb Cortex. 2010;20(5):1175\u201386.","journal-title":"Cereb Cortex"},{"issue":"Pt 3","key":"1640_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/brain\/awu381","volume":"138","author":"J Michely","year":"2015","unstructured":"Michely J, Volz LJ, Barbe MT, Hoffstaedter F, Viswanathan S, Timmermann L, et al. Dopaminergic modulation of motor network dynamics in Parkinson\u2019s disease. Brain. 2015;138(Pt 3):664\u201378.","journal-title":"Brain"},{"issue":"7","key":"1640_CR7","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S1474-4422(13)70123-6","volume":"12","author":"GM Petzinger","year":"2013","unstructured":"Petzinger GM, Fisher BE, McEwen S, Beeler JA, Walsh JP, Jakowec MW. Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson\u2019s disease. Lancet Neurol. 2013;12(7):716\u201326.","journal-title":"Lancet Neurol"},{"key":"1640_CR8","volume-title":"European physiotherapy guideline for Parkinson\u2019s disease","author":"SHJMM Keus","year":"2014","unstructured":"Keus SHJMM, Graziano M, Paltamaa J, Pelosin E, Domingos J, Br\u00fchlmann S, Ramaswamy B, Prins J, Struiksma C, Rochester L, Nieuwboer A, Bloem B. European physiotherapy guideline for Parkinson\u2019s disease. The Netherlands: KNGF\/ ParkinsonNet; 2014."},{"issue":"10050","key":"1640_CR9","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/S0140-6736(16)31325-3","volume":"388","author":"A Mirelman","year":"2016","unstructured":"Mirelman A, Rochester L, Maidan I, Del Din S, Alcock L, Nieuwhof F, et al. Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trial. Lancet. 2016;388(10050):1170\u201382.","journal-title":"Lancet"},{"issue":"8","key":"1640_CR10","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/mds.27372","volume":"33","author":"SH Fox","year":"2018","unstructured":"Fox SH, Katzenschlager R, Lim SY, Barton B, de Bie RMA, Seppi K, et al. International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson\u2019s disease. Mov Disord. 2018;33(8):1248\u201366.","journal-title":"Mov Disord"},{"issue":"10","key":"1640_CR11","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1177\/1545968320952799","volume":"34","author":"DLM Radder","year":"2020","unstructured":"Radder DLM, Ligia Silva de Lima A, Domingos J, Keus SHJ, van Nimwegen M, Bloem BR, et al. Physiotherapy in Parkinson\u2019s disease: A Meta-Analysis of present treatment modalities. Neurorehabil Neural Repair. 2020;34(10):871\u201380.","journal-title":"Neurorehabil Neural Repair"},{"issue":"1","key":"1640_CR12","first-page":"CD013856","volume":"1","author":"M Ernst","year":"2023","unstructured":"Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, et al. Physical exercise for people with Parkinson\u2019s disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023;1(1):CD013856.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"1640_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2522\/ptj.20140374","volume":"95","author":"M Benka Wallen","year":"2015","unstructured":"Benka Wallen M, Franzen E, Nero H, Hagstromer M. Levels and patterns of physical activity and sedentary behavior in elderly people with mild to moderate Parkinson disease. Phys Ther. 2015;95(8):1135\u201341.","journal-title":"Phys Ther"},{"issue":"12","key":"1640_CR14","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1007\/s00415-011-6097-7","volume":"258","author":"M van Nimwegen","year":"2011","unstructured":"van Nimwegen M, Speelman AD, Hofman-van Rossum EJ, Overeem S, Deeg DJ, Borm GF, et al. Physical inactivity in Parkinson\u2019s disease. J Neurol. 2011;258(12):2214\u201321.","journal-title":"J Neurol"},{"issue":"10291","key":"1640_CR15","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"2","key":"1640_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.physio.2013.05.003","volume":"100","author":"AD Speelman","year":"2014","unstructured":"Speelman AD, van Nimwegen M, Bloem BR, Munneke M. Evaluation of implementation of the parkfit program: A multifaceted intervention aimed to promote physical activity in patients with Parkinson\u2019s disease. Physiotherapy. 2014;100(2):134\u201341.","journal-title":"Physiotherapy"},{"issue":"2","key":"1640_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/17434440.2018.1425613","volume":"15","author":"G Tieri","year":"2018","unstructured":"Tieri G, Morone G, Paolucci S, Iosa M. Virtual reality in cognitive and motor rehabilitation: facts, fiction and fallacies. Expert Rev Med Devices. 2018;15(2):107\u201317.","journal-title":"Expert Rev Med Devices"},{"issue":"22","key":"1640_CR18","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3109\/09638288.2012.670036","volume":"34","author":"GN Lewis","year":"2012","unstructured":"Lewis GN, Rosie JA. Virtual reality games for movement rehabilitation in neurological conditions: how do we Meet the needs and expectations of the users? Disabil Rehabil. 2012;34(22):1880\u20136.","journal-title":"Disabil Rehabil"},{"issue":"8","key":"1640_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41582-020-0370-2","volume":"16","author":"CG Canning","year":"2020","unstructured":"Canning CG, Allen NE, Nackaerts E, Paul SS, Nieuwboer A, Gilat M. Virtual reality in research and rehabilitation of gait and balance in Parkinson disease. Nat Rev Neurol. 2020;16(8):409\u201325.","journal-title":"Nat Rev Neurol"},{"key":"1640_CR20","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.3389\/fpsyg.2018.02120","volume":"9","author":"D Perez-Marcos","year":"2018","unstructured":"Perez-Marcos D, Bieler-Aeschlimann M, Serino A. Virtual reality as a vehicle to empower Motor-Cognitive neurorehabilitation. Front Psychol. 2018;9:2120.","journal-title":"Front Psychol"},{"key":"1640_CR21","first-page":"CD010760","volume":"12","author":"K Dockx","year":"2016","unstructured":"Dockx K, Bekkers EM, Van den Bergh V, Ginis P, Rochester L, Hausdorff JM, et al. Virtual reality for rehabilitation in Parkinson\u2019s disease. Cochrane Database Syst Rev. 2016;12:CD010760.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1640_CR22","first-page":"31","volume":"43","author":"JW Krakauer","year":"2018","unstructured":"Krakauer JW, Cortes JC. A non-task-oriented approach based on high-dose playful movement exploration for rehabilitation of the upper limb early after stroke: A proposal. NeuroRehabilitation. 2018;43(1):31\u201340.","journal-title":"NeuroRehabilitation"},{"issue":"5","key":"1640_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/15459683211000730","volume":"35","author":"JW Krakauer","year":"2021","unstructured":"Krakauer JW, Kitago T, Goldsmith J, Ahmad O, Roy P, Stein J, et al. Comparing a novel neuroanimation experience to conventional therapy for High-Dose intensive Upper-Limb training in subacute stroke: the SMARTS2 randomized trial. Neurorehabil Neural Repair. 2021;35(5):393\u2013405.","journal-title":"Neurorehabil Neural Repair"},{"issue":"1","key":"1640_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40945-022-00139-0","volume":"12","author":"RC Stockley","year":"2022","unstructured":"Stockley RC, Christian DL. A focus group study of therapists\u2019 views on using a novel neuroanimation virtual reality game to deliver intensive upper-limb rehabilitation early after stroke. Arch Physiother. 2022;12(1):15.","journal-title":"Arch Physiother"},{"issue":"12","key":"1640_CR25","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u2013601.","journal-title":"Mov Disord"},{"issue":"3","key":"1640_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/mdc3.12921","volume":"7","author":"S Schade","year":"2020","unstructured":"Schade S, Mollenhauer B, Trenkwalder C. Levodopa equivalent dose conversion factors: an updated proposal including Opicapone and Safinamide. Mov Disord Clin Pract. 2020;7(3):343\u20135.","journal-title":"Mov Disord Clin Pract"},{"issue":"9","key":"1640_CR27","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/mds.26572","volume":"31","author":"BR Bloem","year":"2016","unstructured":"Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B, et al. Measurement instruments to assess posture, gait, and balance in Parkinson\u2019s disease: critique and recommendations. Mov Disord. 2016;31(9):1342\u201355.","journal-title":"Mov Disord"},{"issue":"2","key":"1640_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/mdc3.12874","volume":"7","author":"R Bouca-Machado","year":"2020","unstructured":"Bouca-Machado R, Duarte GS, Patriarca M, Castro Caldas A, Alarcao J, Fernandes RM, et al. Measurement instruments to assess functional mobility in Parkinson\u2019s disease: A systematic review. Mov Disord Clin Pract. 2020;7(2):129\u201339.","journal-title":"Mov Disord Clin Pract"},{"issue":"15","key":"1640_CR29","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement disorder Society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129\u201370.","journal-title":"Mov Disord"},{"issue":"2","key":"1640_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/NPT.0b013e31821a620c","volume":"35","author":"AL Leddy","year":"2011","unstructured":"Leddy AL, Crowner BE, Earhart GM. Utility of the Mini-BESTest, bestest, and bestest sections for balance assessments in individuals with Parkinson disease. J Neurol Phys Ther. 2011;35(2):90\u20137.","journal-title":"J Neurol Phys Ther"},{"issue":"2","key":"1640_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/mds.27233","volume":"33","author":"M Skorvanek","year":"2018","unstructured":"Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, et al. Global scales for cognitive screening in Parkinson\u2019s disease: critique and recommendations. Mov Disord. 2018;33(2):208\u201318.","journal-title":"Mov Disord"},{"issue":"3","key":"1640_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF02260863","volume":"4","author":"V Peto","year":"1995","unstructured":"Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson\u2019s disease. Qual Life Res. 1995;4(3):241\u20138.","journal-title":"Qual Life Res"},{"key":"1640_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jbiomech.2019.05.039","volume":"92","author":"F Ferreira","year":"2019","unstructured":"Ferreira F, Gago MF, Bicho E, Carvalho C, Mollaei N, Rodrigues L, et al. Gait stride-to-stride variability and foot clearance pattern analysis in idiopathic Parkinson\u2019s disease and vascular parkinsonism. J Biomech. 2019;92:98\u2013104.","journal-title":"J Biomech"},{"issue":"1","key":"1640_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/s140100443","volume":"14","author":"F Dadashi","year":"2013","unstructured":"Dadashi F, Mariani B, Rochat S, Bula CJ, Santos-Eggimann B, Aminian K. Gait and foot clearance parameters obtained using shoe-worn inertial sensors in a large-population sample of older adults. Sens (Basel). 2013;14(1):443\u201357.","journal-title":"Sens (Basel)"},{"issue":"15","key":"1640_CR35","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1016\/j.jbiomech.2010.07.003","volume":"43","author":"B Mariani","year":"2010","unstructured":"Mariani B, Hoskovec C, Rochat S, Bula C, Penders J, Aminian K. 3D gait assessment in young and elderly subjects using foot-worn inertial sensors. J Biomech. 2010;43(15):2999\u20133006.","journal-title":"J Biomech"},{"issue":"1","key":"1640_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1109\/TBME.2012.2227317","volume":"60","author":"B Mariani","year":"2013","unstructured":"Mariani B, Jimenez MC, Vingerhoets FJ, Aminian K. On-shoe wearable sensors for gait and turning assessment of patients with Parkinson\u2019s disease. IEEE Trans Biomed Eng. 2013;60(1):155\u20138.","journal-title":"IEEE Trans Biomed Eng"},{"key":"1640_CR37","doi-asserted-by":"publisher","first-page":"637620","DOI":"10.3389\/fneur.2021.637620","volume":"12","author":"R Bouca-Machado","year":"2021","unstructured":"Bouca-Machado R, Branco D, Fonseca G, Fernandes R, Abreu D, Guerreiro T, et al. Kinematic and clinical outcomes to evaluate the efficacy of a multidisciplinary intervention on functional mobility in Parkinson\u2019s disease. Front Neurol. 2021;12:637620.","journal-title":"Front Neurol"},{"issue":"4","key":"1640_CR38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.gaitpost.2012.09.025","volume":"37","author":"B Galna","year":"2013","unstructured":"Galna B, Lord S, Rochester L. Is gait variability reliable in older adults and Parkinson\u2019s disease? Towards an optimal testing protocol. Gait Posture. 2013;37(4):580\u20135.","journal-title":"Gait Posture"},{"key":"1640_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.procs.2015.09.273","volume":"67","author":"AIRA Martins","year":"2015","unstructured":"Martins AIRA, Queir\u00f3s A, Silva A, Pacheco Rocha N. European Portuguese validation of the system usability scale (SUS). Procedia Comput Sci. 2015;67:293\u2013300.","journal-title":"Procedia Comput Sci"},{"key":"1640_CR40","unstructured":"Brooke JSAqadusIPJ B, Thomas, Weerdmeester B, editors. Usability evaluation in industry (pp. 189\u201394). London, UK: Taylor & Francis."},{"issue":"3","key":"1640_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1207\/s15327108ijap0303_3","volume":"3","author":"RS Kennedy","year":"1993","unstructured":"Kennedy RS, Lane NE, Berbaum KS, Lilienthal MG. Simulator sickness questionnaire: an enhanced method for quantifying simulator sickness. Int J Aviat Psychol. 1993;3(3):203\u201320.","journal-title":"Int J Aviat Psychol"},{"issue":"4","key":"1640_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1590\/1980-5918.030.004.ao04","volume":"30","author":"MEBAA Bueno","year":"2017","unstructured":"Bueno MEBAA, Terra MB, Santos HBC, Marquioli JM, Santos SMS. Comparison of three physical therapy interventions with an emphasis on the gait of individuals with Parkinson\u2019s disease. Fisioter Mov. 2017;30(4):691\u2013701.","journal-title":"Fisioter Mov"},{"key":"1640_CR43","unstructured":"Rosenthal R. Parametric measures of effect size. In: Cooper H, Hedges LV, editors. The handbook of research synthesis. Russell Sage Foundation; 1994. pp. 231\u201344."},{"key":"1640_CR44","unstructured":"Cohen J. Statistical Power Analysis for the Behavioral Sciences. In: Routledge NY, editor. 2nd Ed ed1988."},{"key":"1640_CR45","doi-asserted-by":"publisher","unstructured":"Lewis JR. The system usability scale: Past Present, and Future. Int J Human\u2013Computer Interact. 2018. https:\/\/doi.org\/10.1080\/10447318.2018.1455307.","DOI":"10.1080\/10447318.2018.1455307"},{"key":"1640_CR46","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fneur.2019.00062","volume":"10","author":"M Olson","year":"2019","unstructured":"Olson M, Lockhart TE, Lieberman A. Motor learning deficits in Parkinson\u2019s disease (PD) and their effect on training response in gait and balance: A narrative review. Front Neurol. 2019;10:62.","journal-title":"Front Neurol"},{"issue":"3","key":"1640_CR47","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/1545968318763750","volume":"32","author":"I Maidan","year":"2018","unstructured":"Maidan I, Nieuwhof F, Bernad-Elazari H, Bloem BR, Giladi N, Hausdorff JM, et al. Evidence for differential effects of 2 forms of exercise on prefrontal plasticity during walking in Parkinson\u2019s disease. Neurorehabil Neural Repair. 2018;32(3):200\u20138.","journal-title":"Neurorehabil Neural Repair"},{"issue":"2","key":"1640_CR48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/gerona\/glq201","volume":"66","author":"A Mirelman","year":"2011","unstructured":"Mirelman A, Maidan I, Herman T, Deutsch JE, Giladi N, Hausdorff JM. Virtual reality for gait training: can it induce motor learning to enhance complex walking and reduce fall risk in patients with Parkinson\u2019s disease? J Gerontol Biol Sci Med Sci. 2011;66(2):234\u201340.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"7","key":"1640_CR49","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(19)30044-4","volume":"18","author":"A Mirelman","year":"2019","unstructured":"Mirelman A, Bonato P, Camicioli R, Ellis TD, Giladi N, Hamilton JL, et al. Gait impairments in Parkinson\u2019s disease. Lancet Neurol. 2019;18(7):697\u2013708.","journal-title":"Lancet Neurol"},{"key":"1640_CR50","doi-asserted-by":"crossref","unstructured":"Putrino D, Krakauer JW. Neurotechnology\u2019s Prospects for Bringing About Meaningful Reductions in Neurological Impairment. Neurorehabil Neural Repair. 2022:15459683221137341.","DOI":"10.1177\/15459683221137341"},{"key":"1640_CR51","doi-asserted-by":"publisher","first-page":"739742","DOI":"10.3389\/fpsyt.2021.739742","volume":"12","author":"S Bouchard","year":"2021","unstructured":"Bouchard S, Berthiaume M, Robillard G, Forget H, Daudelin-Peltier C, Renaud P, et al. Arguing in favor of revising the simulator sickness questionnaire factor structure when assessing side effects induced by immersions in virtual reality. Front Psychiatry. 2021;12:739742.","journal-title":"Front Psychiatry"},{"key":"1640_CR52","doi-asserted-by":"crossref","unstructured":"Bimberg P, Weissker T, Kulik A, editors. On the Usage of the Simulator Sickness Questionnaire for Virtual Reality Research. 2020 IEEE Conference on Virtual Reality and 3D User Interfaces Abstracts and Workshops (VRW); 2020 22\u201326 March 2020.","DOI":"10.1109\/VRW50115.2020.00098"}],"container-title":["Journal of NeuroEngineering and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12984-025-01640-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12984-025-01640-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12984-025-01640-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T12:04:18Z","timestamp":1749643458000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroengrehab.biomedcentral.com\/articles\/10.1186\/s12984-025-01640-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1640"],"URL":"https:\/\/doi.org\/10.1186\/s12984-025-01640-w","relation":{},"ISSN":["1743-0003"],"issn-type":[{"value":"1743-0003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the CNS Ethics Committee (Ref. 03-2020) and performed in accordance with national legislation and the Declaration of Helsinki. Individuals who agreed to participate were asked to provide written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants consented to these data being published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.DPS was granted by Santa Casa da Miseric\u00f3rdia de Lisboa (\u201cPr\u00e9mio Jo\u00e3o Lobo Antunes\u201d) for a project unrelated to the present manuscript. RA was an employee and shareholder of MindMaze SA. JWK has consulted for and has options in MindMaze, Emerja, and Meta. JJF has provided consultancy for AbbVie, BIAL, Biogen, Lundbeck, and Sunovion, has received grants from Angelini, Novartis, Medtronic, AbbVie, Zambon, BIAL, Biogen, and Grunenthal, and has received speaker fees for BIAL, Ono, SK Chemical, Abbvie and Infucure.  All other authors have no financial disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}